The Centers for Disease Control and Prevention has updated its interim guidance for health care professionals for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. The guidance includes criteria for who should be evaluated for MERS-CoV, which have been updated to include individuals with fever and pneumonia or acute respiratory distress syndrome who have a history of being in a health care facility as a patient, worker or visitor in South Korea within 14 days of symptom onset. The guidance also contains guidelines for the evaluation and management of close contacts, as well as reporting, laboratory testing and infection control. CDC said it will update the infection control guidance in the coming days. MERS-CoV, which can be fatal, was first reported in Saudi Arabia in 2012 and has since spread to several other countries, including South Korea, where an outbreak was first reported in May. For more, including common signs and symptoms, see the CDC’s MERS webpage

Related News Articles

Headline
The AHA and the Hospital Capacity Management Consortium will host a webinar Sept. 4 on the use of predictive analytics within hospital capacity management,…
Headline
The AHA Quest for Quality Prize honors hospitals and health systems committed to leadership and innovation in improving quality and advancing health. Learn how…
Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Headline
The AHA’s Society for Health Care Strategy & Market Development Aug. 21 announced Donna Teach, chief marketing and communications officer for Nationwide…
Headline
The FBI Aug. 20 released an advisory warning of malicious activity by Russian cyber actors targeting end-of-life devices running an unpatched vulnerability in…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…